Master in Medical-Pharmaceutical Biotechnology

For Master in Medical-Pharmaceutical Biotechnology, tuition is 3,163 EUR per year.

Medical-Pharmaceutical Biotechnology applies biological and chemical science to the development of medicines, diagnostics, and other health-related products. Typical subjects include molecular biology, biochemistry, genetics, pharmacology, and microbiology, together with more applied courses on drug development, biotechnological production processes, and regulatory aspects of the pharmaceutical industry. Students learn laboratory techniques used to study cells, proteins, and genetic material, as well as how these tools are applied to create or improve treatments, vaccines, and diagnostic tests. The field sits at the intersection of basic biological research and applied industrial science, so coursework tends to combine theoretical study with practical laboratory work. Graduates commonly find roles in pharmaceutical and biotechnology companies, diagnostic laboratories, quality control, and research institutions, and the degree can also serve as preparation for further postgraduate research. This master's program in Medical-Pharmaceutical Biotechnology is offered by Università degli Studi di Genova, located in Genova, Italy, and is taught in English over two years. Admission builds on a prior bachelor's degree or an equivalent qualification, reflecting the advanced, specialized nature of the subject matter covered at this level. Over the two years, students are expected to move from consolidating core biological and biochemical knowledge toward more specialized study of pharmaceutical biotechnology applications, often supported by laboratory-based coursework. Delivering the program in English allows the university to welcome an international group of students who are interested in the pharmaceutical and biotechnology sectors, while the degree remains grounded in the Italian university system and its approach to life science education.